The scarcity of malignant Hodgkin and Reed-Sternberg cells hampers tissue-based comprehensive genomic profiling of classic Hodgkin lymphoma (cHL). By contrast, liquid biopsies show promise for molecular profiling of cHL due to relatively high circulating tumour DNA (ctDNA) levels1-4.
Nonalcoholic steatohepatitis (NASH) is the progressive form of non-alcoholic fatty liver disease (NAFLD), and is the most common cause of liver...
Follow three patient case studies in this interactive module
Bayer HealthCare announced that the FDA Cardiovascular and Renal Drugs Advisory Committee recommended approval of the oral soluble guanylate cyclase...
NICE now recommends Imbruvica to treat mantle cell lymphoma.
The FDA on 30 August 2012 approved Linzess (linaclotide) from Forest Labs and Ironwood Pharma, to treat Chronic Idiopathic Constipation...
The FDA Neurological Devices Advisory Panel of the Medical Devices Advisory Committee voted (7 yes; 3 no; 2 abstain) that...